Lytix Biopharma AS: Lytix Biopharma announces the publication of a paper describing how LTX-315 mediates antitumor activity through multiple pathways

Press/Media

PeriodMar 23 2024

Media coverage

1

Media coverage

  • TitleLytix Biopharma AS: Lytix Biopharma announces the publication of a paper describing how LTX-315 mediates antitumor activity through multiple pathways
    Media name/outletNordic Daily
    Country/TerritoryFinland
    Date03/23/24
    PersonsLorenzo Galluzzi
View all 1
View less